Grinde Sarah L. 4
4 · ROCHESTER MEDICAL CORPORATION · Filed Dec 14, 2012
Insider Transaction Report
Form 4
Grinde Sarah L.
VP, Development and Research
Transactions
- Purchase
Common Stock
2012-12-12$9.90/sh+500$4,950→ 3,223 total
Footnotes (1)
- [F1]Includes restricted stock awards.